Anaplastic Plasmacytoma - 139 Studies Found Completed : Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-12-05 : Drug: bortezomib Drug: hydroxychloroquine Terminated : Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-12-01 : Biological: rituximab Drug: lenalidomide Completed : Activated White Blood Cells in Treating Patients Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Stage II or Stage III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-11-30 : Biological: therapeutic autologous lymphocytes Completed : High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-09-05 : Biological: filgrastim Biological: pegfilg Completed : Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-08-31 : Drug: bortezomib IV Withdrawn : Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-07-17 : Drug: Arsenic trioxide Arsenic Completed : Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-07-10 : Biological: CMV pp65 peptide G Completed : Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-06-04 : Biological: bevacizumab Genetic: gene expr Active, not recruiting : Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain : Multiple Myeloma and Plasma Cell Neoplasm Pain : 2007-06-04 : Drug: Pamidronate 90 mg by IV Completed : Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-05-23 : Drug: cyclophosphamide 300 mg/ <<< Previous | Next >>>
